Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03807479
Title Study in Patients With Chronic Leukemia, Where Previous Therapy Failed, and Who Will be Treated With Ponatinib as Second Line Therapy (PONS)
Acronym PONS
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors GWT-TUD GmbH
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU

Facility Status City State Zip Country Details
University Hospital Halle (Saale) Saxony-Anhalt 06097 Germany Details
University Hospital RWTH Aachen,Clinic for Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Department IV Aachen 52074 Germany Details
Charité University Medicine Berlin - Medical Clinic, Department of Hematology, Oncology and Tumor Immunology Berlin 13353 Germany Details
University Hospital Essen gGmbH, Westdeutsches Tumorzentrum; Internal Medicine (Tumor Research) Essen 45122 Germany Details
University Medicine Greifswald, Clinic and Policlinic - Internal Medicine C - Hematology and Oncology Greifswald 17475 Germany Details
Asklepios Clinic St. Georg - Department of Oncology, Section Hematology Hamburg 20099 Germany Details
University Hospital Mannheim GmbH, III. Medical Clinic for Hematology and Oncology Mannheim 68167 Germany Details
Clinic for Hematologie Marburg 35043 Germany Details
UKRUB University Hospital of Ruhr-University Bochum, Clinic for Hematology and Oncology Minden 32429 Germany Details
University Hospital Ulm - Department for internal medicine III Ulm 89081 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field